CN103006569B - 改善采用水分散体包衣的膜控缓释微丸抗老化性能的方法 - Google Patents
改善采用水分散体包衣的膜控缓释微丸抗老化性能的方法 Download PDFInfo
- Publication number
- CN103006569B CN103006569B CN201110285119.4A CN201110285119A CN103006569B CN 103006569 B CN103006569 B CN 103006569B CN 201110285119 A CN201110285119 A CN 201110285119A CN 103006569 B CN103006569 B CN 103006569B
- Authority
- CN
- China
- Prior art keywords
- release
- capsule core
- film
- capsule
- sustained
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000000576 coating method Methods 0.000 title claims abstract description 79
- 239000011248 coating agent Substances 0.000 title claims abstract description 71
- 230000032683 aging Effects 0.000 title claims abstract description 42
- 239000006185 dispersion Substances 0.000 title claims abstract description 36
- 238000000034 method Methods 0.000 title abstract description 66
- 239000002775 capsule Substances 0.000 claims abstract description 248
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 52
- 229920000642 polymer Polymers 0.000 claims abstract description 51
- 239000003814 drug Substances 0.000 claims abstract description 30
- 229940079593 drug Drugs 0.000 claims abstract description 19
- 229920002472 Starch Polymers 0.000 claims description 48
- 239000008107 starch Substances 0.000 claims description 48
- 235000019698 starch Nutrition 0.000 claims description 48
- ZBOQQGAVXCUYJM-UHFFFAOYSA-N butanedioic acid;1-[4-(2-methoxyethyl)phenoxy]-3-(propan-2-ylamino)propan-2-ol Chemical compound OC(=O)CCC(O)=O.COCCC1=CC=C(OCC(O)CNC(C)C)C=C1 ZBOQQGAVXCUYJM-UHFFFAOYSA-N 0.000 claims description 37
- 239000011734 sodium Substances 0.000 claims description 37
- 229910052708 sodium Inorganic materials 0.000 claims description 36
- 229960001300 metoprolol tartrate Drugs 0.000 claims description 30
- WUBVEMGCQRSBBT-UHFFFAOYSA-N tert-butyl 4-(trifluoromethylsulfonyloxy)-3,6-dihydro-2h-pyridine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCC(OS(=O)(=O)C(F)(F)F)=CC1 WUBVEMGCQRSBBT-UHFFFAOYSA-N 0.000 claims description 30
- 229940031703 low substituted hydroxypropyl cellulose Drugs 0.000 claims description 22
- 229920000881 Modified starch Polymers 0.000 claims description 21
- 239000007884 disintegrant Substances 0.000 claims description 19
- 229920000523 polyvinylpolypyrrolidone Polymers 0.000 claims description 18
- 235000013809 polyvinylpolypyrrolidone Nutrition 0.000 claims description 18
- 239000012528 membrane Substances 0.000 claims description 11
- 230000003578 releasing effect Effects 0.000 claims description 10
- -1 hydroxypropyl Chemical class 0.000 claims description 6
- 229920002678 cellulose Polymers 0.000 claims description 4
- 239000001913 cellulose Substances 0.000 claims description 4
- 239000002075 main ingredient Substances 0.000 claims description 3
- AQLLBJAXUCIJSR-UHFFFAOYSA-N OC(=O)C[Na] Chemical compound OC(=O)C[Na] AQLLBJAXUCIJSR-UHFFFAOYSA-N 0.000 claims description 2
- 239000000463 material Substances 0.000 abstract description 43
- 239000006187 pill Substances 0.000 abstract description 36
- 238000003860 storage Methods 0.000 abstract description 8
- 230000001934 delay Effects 0.000 abstract description 4
- 238000013270 controlled release Methods 0.000 abstract description 2
- 238000013268 sustained release Methods 0.000 description 99
- 239000012730 sustained-release form Substances 0.000 description 99
- 238000003556 assay Methods 0.000 description 48
- 229940032147 starch Drugs 0.000 description 45
- 239000007788 liquid Substances 0.000 description 41
- 230000004584 weight gain Effects 0.000 description 39
- 235000019786 weight gain Nutrition 0.000 description 39
- 238000002360 preparation method Methods 0.000 description 37
- 238000005516 engineering process Methods 0.000 description 36
- 206010042674 Swelling Diseases 0.000 description 35
- 230000008961 swelling Effects 0.000 description 35
- 239000008188 pellet Substances 0.000 description 34
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 34
- 239000007888 film coating Substances 0.000 description 31
- 238000009501 film coating Methods 0.000 description 31
- 230000002459 sustained effect Effects 0.000 description 31
- 230000008569 process Effects 0.000 description 25
- 239000012530 fluid Substances 0.000 description 17
- 238000012360 testing method Methods 0.000 description 16
- 238000010438 heat treatment Methods 0.000 description 15
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 14
- 229940016286 microcrystalline cellulose Drugs 0.000 description 14
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 14
- 239000008108 microcrystalline cellulose Substances 0.000 description 14
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 12
- 239000000243 solution Substances 0.000 description 12
- 230000000694 effects Effects 0.000 description 10
- 239000000499 gel Substances 0.000 description 10
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 9
- 230000035699 permeability Effects 0.000 description 9
- 239000000047 product Substances 0.000 description 9
- 230000007423 decrease Effects 0.000 description 8
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 8
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 8
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 8
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 8
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 8
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 7
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 description 7
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 7
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 7
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 6
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 6
- 239000012738 dissolution medium Substances 0.000 description 6
- 238000013265 extended release Methods 0.000 description 6
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 6
- 239000000693 micelle Substances 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- 229920003163 Eudragit® NE 30 D Polymers 0.000 description 5
- 238000013461 design Methods 0.000 description 5
- 210000002784 stomach Anatomy 0.000 description 5
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 4
- DOOTYTYQINUNNV-UHFFFAOYSA-N Triethyl citrate Chemical compound CCOC(=O)CC(O)(C(=O)OCC)CC(=O)OCC DOOTYTYQINUNNV-UHFFFAOYSA-N 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 238000010790 dilution Methods 0.000 description 4
- 239000012895 dilution Substances 0.000 description 4
- 239000012153 distilled water Substances 0.000 description 4
- 238000010812 external standard method Methods 0.000 description 4
- 239000000706 filtrate Substances 0.000 description 4
- 229920002521 macromolecule Polymers 0.000 description 4
- 239000004014 plasticizer Substances 0.000 description 4
- 238000006467 substitution reaction Methods 0.000 description 4
- 229960005137 succinic acid Drugs 0.000 description 4
- 235000013769 triethyl citrate Nutrition 0.000 description 4
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 3
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 3
- 239000001828 Gelatine Substances 0.000 description 3
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 3
- 229920002125 Sokalan® Polymers 0.000 description 3
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 3
- 150000001336 alkenes Chemical class 0.000 description 3
- 235000010410 calcium alginate Nutrition 0.000 description 3
- 239000000648 calcium alginate Substances 0.000 description 3
- 229960002681 calcium alginate Drugs 0.000 description 3
- OKHHGHGGPDJQHR-YMOPUZKJSA-L calcium;(2s,3s,4s,5s,6r)-6-[(2r,3s,4r,5s,6r)-2-carboxy-6-[(2r,3s,4r,5s,6r)-2-carboxylato-4,5,6-trihydroxyoxan-3-yl]oxy-4,5-dihydroxyoxan-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylate Chemical compound [Ca+2].O[C@@H]1[C@H](O)[C@H](O)O[C@@H](C([O-])=O)[C@H]1O[C@H]1[C@@H](O)[C@@H](O)[C@H](O[C@H]2[C@H]([C@@H](O)[C@H](O)[C@H](O2)C([O-])=O)O)[C@H](C(O)=O)O1 OKHHGHGGPDJQHR-YMOPUZKJSA-L 0.000 description 3
- 229960001631 carbomer Drugs 0.000 description 3
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 3
- 235000010980 cellulose Nutrition 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 238000004090 dissolution Methods 0.000 description 3
- 238000001704 evaporation Methods 0.000 description 3
- 230000008020 evaporation Effects 0.000 description 3
- 230000004927 fusion Effects 0.000 description 3
- 229920000159 gelatin Polymers 0.000 description 3
- 235000019322 gelatine Nutrition 0.000 description 3
- 239000003292 glue Substances 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 229920000609 methyl cellulose Polymers 0.000 description 3
- 239000001923 methylcellulose Substances 0.000 description 3
- 235000010981 methylcellulose Nutrition 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- HNJBEVLQSNELDL-UHFFFAOYSA-N pyrrolidin-2-one Chemical compound O=C1CCCN1 HNJBEVLQSNELDL-UHFFFAOYSA-N 0.000 description 3
- 235000010413 sodium alginate Nutrition 0.000 description 3
- 239000000661 sodium alginate Substances 0.000 description 3
- 229940005550 sodium alginate Drugs 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 235000002906 tartaric acid Nutrition 0.000 description 3
- 239000011975 tartaric acid Substances 0.000 description 3
- 229920003157 Eudragit® RL 30 D Polymers 0.000 description 2
- 229920003152 Eudragit® RS polymer Polymers 0.000 description 2
- 206010021703 Indifference Diseases 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 2
- WEVYAHXRMPXWCK-UHFFFAOYSA-N acetonitrile Substances CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- 229920002301 cellulose acetate Polymers 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000003111 delayed effect Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000009792 diffusion process Methods 0.000 description 2
- 230000010339 dilation Effects 0.000 description 2
- 238000011978 dissolution method Methods 0.000 description 2
- FSXVSUSRJXIJHB-UHFFFAOYSA-M ethyl prop-2-enoate;methyl 2-methylprop-2-enoate;trimethyl-[2-(2-methylprop-2-enoyloxy)ethyl]azanium;chloride Chemical compound [Cl-].CCOC(=O)C=C.COC(=O)C(C)=C.CC(=C)C(=O)OCC[N+](C)(C)C FSXVSUSRJXIJHB-UHFFFAOYSA-M 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000000945 filler Substances 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- FPLYNRPOIZEADP-UHFFFAOYSA-N octylsilane Chemical group CCCCCCCC[SiH3] FPLYNRPOIZEADP-UHFFFAOYSA-N 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- ULWHHBHJGPPBCO-UHFFFAOYSA-N propane-1,1-diol Chemical class CCC(O)O ULWHHBHJGPPBCO-UHFFFAOYSA-N 0.000 description 2
- 239000013558 reference substance Substances 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 238000010008 shearing Methods 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 2
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 2
- 239000011122 softwood Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000002604 ultrasonography Methods 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- 229920000856 Amylose Polymers 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003679 aging effect Effects 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 239000003405 delayed action preparation Substances 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 238000005265 energy consumption Methods 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 239000002360 explosive Substances 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000008676 import Effects 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 229960002237 metoprolol Drugs 0.000 description 1
- IUBSYMUCCVWXPE-UHFFFAOYSA-N metoprolol Chemical compound COCCC1=CC=C(OCC(O)CNC(C)C)C=C1 IUBSYMUCCVWXPE-UHFFFAOYSA-N 0.000 description 1
- 229940054181 metoprolol tartrate 25 mg Drugs 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 229920002627 poly(phosphazenes) Polymers 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 229940080313 sodium starch Drugs 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 229940095064 tartrate Drugs 0.000 description 1
- 239000001069 triethyl citrate Substances 0.000 description 1
- VMYFZRTXGLUXMZ-UHFFFAOYSA-N triethyl citrate Natural products CCOC(=O)C(O)(C(=O)OCC)C(=O)OCC VMYFZRTXGLUXMZ-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
Abstract
Description
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110285119.4A CN103006569B (zh) | 2011-09-23 | 2011-09-23 | 改善采用水分散体包衣的膜控缓释微丸抗老化性能的方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110285119.4A CN103006569B (zh) | 2011-09-23 | 2011-09-23 | 改善采用水分散体包衣的膜控缓释微丸抗老化性能的方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103006569A CN103006569A (zh) | 2013-04-03 |
CN103006569B true CN103006569B (zh) | 2017-11-24 |
Family
ID=47956036
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201110285119.4A Active CN103006569B (zh) | 2011-09-23 | 2011-09-23 | 改善采用水分散体包衣的膜控缓释微丸抗老化性能的方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103006569B (zh) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101612171A (zh) * | 2008-06-27 | 2009-12-30 | 武汉爱民制药有限公司 | 银杏叶提取物缓释微丸及其制备方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100451110C (zh) * | 2005-12-06 | 2009-01-14 | 青岛科技大学 | 一种用于酶固定化的硅胶负载多孔壳聚糖载体 |
CN101190180B (zh) * | 2006-11-20 | 2011-03-30 | 北京利龄恒泰药业有限公司 | 一种美托洛尔的缓释药物组合物及其制备方法 |
JP2009191036A (ja) * | 2008-02-15 | 2009-08-27 | Ss Pharmaceut Co Ltd | 時限放出製剤 |
-
2011
- 2011-09-23 CN CN201110285119.4A patent/CN103006569B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101612171A (zh) * | 2008-06-27 | 2009-12-30 | 武汉爱民制药有限公司 | 银杏叶提取物缓释微丸及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN103006569A (zh) | 2013-04-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101987091B (zh) | 盐酸文拉法辛缓释微丸胶囊 | |
Meka et al. | Preparation of a matrix type multiple-unit gastro retentive floating drug delivery system for captopril based on gas formation technique: in vitro evaluation | |
NO304726B1 (no) | FremgangsmÕte for fremstilling av por÷se cellulosematrikser | |
DK152831B (da) | Fremgangsmaade ved fremstilling af biologisk aktive praeparater med reguleret afgivelse af aktivt stof samt polymerbaseret vaeskeformigt overtraekspraeparat til anvendelse ved fremgangsmaaden | |
CN103211768B (zh) | 单硝酸异山梨酯缓释微丸及采用其的单硝酸异山梨酯速释‑缓释微丸胶囊 | |
CN111643476A (zh) | 一种软胶囊囊壳及其制备方法 | |
CN110585154B (zh) | 一种琥珀酸美托洛尔微丸压片的方法 | |
CN103211791B (zh) | 盐酸文拉法辛膜控缓释微丸胶囊 | |
CN103006569B (zh) | 改善采用水分散体包衣的膜控缓释微丸抗老化性能的方法 | |
CN103211785A (zh) | 阿昔莫司膜控缓释微丸胶囊 | |
CN103191065A (zh) | 塞来昔布新剂型及其制备方法 | |
CN102198112A (zh) | 一种渗透泵型控释片及其制备方法 | |
Zhao et al. | Polymer blends used to prepare nifedipine loaded hollow microspheres for a floating-type oral drug delivery system: In vitro evaluation | |
CN102525989B (zh) | 洛索洛芬钠骨架缓释片 | |
CN104906060A (zh) | 一种吲达帕胺缓释降压片及其制备方法 | |
CN103211783B (zh) | 氢溴酸右美沙芬膜控缓释微丸胶囊 | |
CN103211790B (zh) | 盐酸坦索罗辛膜控缓释微丸胶囊 | |
CN103211795B (zh) | 头孢克洛膜控缓释微丸胶囊 | |
Li et al. | Self-assembled polyelectrolyte complexes films as efficient compression coating layers for controlled-releasing tablets | |
CN103211784B (zh) | 酒石酸托特罗定膜控缓释微丸胶囊 | |
CN103211792B (zh) | 富马酸美托洛尔膜控缓释微丸胶囊 | |
CN103211787B (zh) | 格列吡嗪膜控缓释微丸胶囊 | |
CN104586800B (zh) | 一种培哚普利片及其粉末的直接压片工艺 | |
CN103211798A (zh) | 氯沙坦钾膜控缓释微丸胶囊 | |
CN103211788B (zh) | 硝苯地平膜控缓释微丸胶囊 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information | ||
CB02 | Change of applicant information |
Address after: 100141 Beijing city Fengtai District Xiaotun Road No. 8 purple Park office block C C510 Applicant after: Beijing Tianheng Drug Research Institute Address before: 100141 Beijing City, Fengtai District Jiang Jia Fen No. 329 Beijing Tianheng Pharmaceutical Institute Applicant before: TEAM ACADEMY OF PHARMACEUTICAL SCIENCE |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Improvement of anti-aging properties of membrane controlled release pellets coated with water dispersions Effective date of registration: 20210125 Granted publication date: 20171124 Pledgee: Beijing Zhongguancun bank Limited by Share Ltd. Pledgor: Beijing Tianheng Drug Research Institute Registration number: Y2021990000104 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20230217 Granted publication date: 20171124 Pledgee: Beijing Zhongguancun bank Limited by Share Ltd. Pledgor: Beijing Tianheng Drug Research Institute Registration number: Y2021990000104 |